Document Detail

Inflammatory processes and Alzheimer's disease.
MedLine Citation:
PMID:  15853506     Owner:  NLM     Status:  MEDLINE    
The inflammatory hypothesis of Alzheimer's disease, which states that anti-inflammatory drugs could have beneficial effects on the pathophysiology of Alzheimer's disease, has been extensively investigated in clinical, epidemiological and basic research studies over the last 20 years. However, despite much hope, the hypothesis remains unproven. Although the results from the first small clinical trial with an anti-inflammatory agent in Alzheimer's disease appeared promising, subsequent trials with a variety of anti-inflammatory agents have failed to show beneficial effects. There are many potential reasons for this including drug selection, drug dose, timing and duration of treatment. This article reviews evidence in support of the inflammatory hypothesis in Alzheimer's disease, as well as the progress of clinical trials using specific anti-inflammatory treatment regimens. It is concluded that such treatments should not be recommended, although additional investigation is warranted.
Sally Walsh; Paul S Aisen
Related Documents :
24851466 - Acute cerebrovascular accident in an 18-year-old male with von willebrand disease.
21607206 - Acute abdominal pain: an unusual medical cause.
8583426 - Reminiscence. a supportive intervention for the person with alzheimer's disease.
24765306 - A case report of a patient with ribbing disease underlines the connections between the ...
24172046 - Social factors affecting seasonal variation in bovine trypanosomiasis on the jos platea...
24027916 - A ten-month diseases survey on wild litopenaeus setiferus (decapoda: penaeidae) from so...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Expert review of neurotherapeutics     Volume:  4     ISSN:  1744-8360     ISO Abbreviation:  Expert Rev Neurother     Publication Date:  2004 Sep 
Date Detail:
Created Date:  2005-04-27     Completed Date:  2006-04-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  101129944     Medline TA:  Expert Rev Neurother     Country:  England    
Other Details:
Languages:  eng     Pagination:  793-8     Citation Subset:  IM    
Department of Neurology, Georgetown University Medical Center, Washington, DC 20057, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alzheimer Disease / epidemiology,  physiopathology*
Anti-Inflammatory Agents / therapeutic use*
Clinical Trials as Topic / methods
Expert Testimony
Inflammation / drug therapy*,  etiology*
Reg. No./Substance:
0/Anti-Inflammatory Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ropivacaine: a pharmacological review.
Next Document:  Utilizing combination therapy in the treatment of Alzheimer's disease.